Lemtrada Does Not Lead to Brain Bleeds, Small Belgian Study Says

Lemtrada Does Not Lead to Brain Bleeds, Small Belgian Study Says

302919

Lemtrada Does Not Lead to Brain Bleeds, Small Belgian Study Says

Lemtrada (alemtuzumab) does not have a substantial effect on blood pressure or platelet counts, and does not lead to bleeding in the brain of multiple sclerosis (MS) patients, according to a small Belgian study. The findings contrast with previous studies showing an increase in blood pressure, stroke, and brain bleeding as serious adverse reactions in people taking Lemtrada. Differences in patient characteristics and treatment regimens should be explored, the researchers said. The study, “Alemtuzumab in…

You must be logged in to read/download the full post.